# Roche Lung-Cancer Drug Candidate Beats Existing Therapies in Late-Stage Trial

> **Open Intelligence Dossier** · First detected: 2026-07-02 16:07 UTC · Category: Business

## Executive Summary
6 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.

## Intelligence Brief
"Roche Lung-Cancer Drug Candidate Beats Existing Therapies in Late-Stage Trial" is generating significant coverage in the Business category, with 6 articles from 6 distinct sources tracked by PULSE so far.


Outlets currently covering the story include Bloomberg.com, Endpoints News, Fierce Biotech and STAT. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.


This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| Bloomberg.com | Roche’s Lung Cancer Pill Outperforms Rival Drugs in Late Trial | [Source Link](https://news.google.com/rss/articles/CBMiswFBVV95cUxQYU4zMWp6N2kwemtxeFRDUk9uTjg2MTdMa1hxbVdxek9tUXkwMlRoRWRVRHJvVDg2bmpMVUJoZ09SaFJKYU1veGdiMEllQ2NTZ1Z3Wl82aU0zb2prSzJGcldWeXRIODZCNDBpcmNfNVVRNzRobC04b0hYaFp4anNzZDgtS2I1bnhaNUJvQWVwanptdnpmcmhhVkFmODg1NFlfcGZGYjBRUjJrNHctdmM5cEZ5QQ?oc=5) |
| Endpoints News | Roche’s KRAS G12C inhibitor beats rivals in head-to-head Phase 3 study | [Source Link](https://news.google.com/rss/articles/CBMilAFBVV95cUxOOENWdm9tdV92WmtpRjdjM1FwSnl5RjJMOHRBX3hIVTZSZkdnaGUtUTVyT3g5Z3R4dUNTU2stVzF5VzEtbW9yb3hteUNqQzNxeHBfeVNrYjFFc3djbjFhSFdfQlctVk03ZDBhcm11X1Q1WUQ4NTN0bjNZZlVMVnZveGNQWC02SWtNTjFnVmY5Y1c1eTV0?oc=5) |
| Fierce Biotech | Roche orchestrates phase 3 KRAS lung cancer win over Amgen, BMS | [Source Link](https://news.google.com/rss/articles/CBMitAFBVV95cUxNbzNZMndOb05KcWRYWThodXFOejBzTzZFUFZKQnBZVERfWklDbDRwMGxneERJWHFzODJIQ1h3Wmk1UDlkeFRtclQ0SUJOd2hzZVZFdWpBQ3pOb3RsRVU3Z0NnVU5vaTNTTms0U1oySVNQUk9oS3djcU8xX1JhYXl1dWVjd2NuVU5aQl9oZzFubElZMUk1X1ZWZzBlUUdVMWk0ZkhOYjZrcHB2dmtjYjRLb3FTdk8?oc=5) |
| STAT | Roche drug sets new standard for KRAS-driven lung cancer | [Source Link](https://news.google.com/rss/articles/CBMiqgFBVV95cUxOOW9LYVlIZmVQcDRIWV93dWFKVVFoQkl6WkFIZEFNZUstZUR0QTNuZHJtN3RTNmxqSTZkUDJiQmNRSVpBVkc1TnExU2k4bExfTmlEVmtoRjRfNkxmX1hITlhvcUZLejJ2clhnQVg1MkhJVnBaWmdSMUlzbnVRYjBRREFoSUlmUDRfdHhxS2s5MVdwanR5SHpYUjd5YkIyZm5Eek9RZllFQ3lVUQ?oc=5) |
| FirstWord PHARMA | Roche's divarasib bests KRAS G12C rivals in late-stage NSCLC study | [Source Link](https://news.google.com/rss/articles/CBMiU0FVX3lxTE9Pa1VfazJGc25VRE9ITG94Rkh3cDF1OUZ4ZGdNMGdmSWdjdDJBbC1hZ2M4OFFtT0NSMEZLNGZSeGYwcm5FNkYtemg4Y1RKRnpia3Zv?oc=5) |
| WSJ | Roche Lung-Cancer Drug Candidate Beats Existing Therapies in Late-Stage Trial | [Source Link](https://news.google.com/rss/articles/CBMivAFBVV95cUxQVXdHMWRqWUJFSEhLakJJNldOZkZjV2liY25aWGdCOFJmd1FJRzlYNmhwMzY3WWtBYkh2M3FldTRrdHFTbkZ4dGwtOW04NTRmbjktdXJwNmw5OUllWE1DZXYxVV91MGp0V21mSVRnUjFFS2pFTHhJS3FqLXZ0N2lPeklYR3NCaVR4MmdZRDFWWHVUWE5aSUJlN1JSbUpSZVJvS1lTQlA1UnhyZ2NfTVVqNzRjUFgtUU83d09vNg?oc=5) |

---
*Canonical Source: https://pulse.byoviral.com/trend/2026-07-02/roche-lung-cancer-drug-candidate-beats-existing-therapies-in-late-stage-trial*